ATLANTA, July 31, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal health IT and readiness agencies, today announced financial results for its fiscal third quarter ended June 30, 2024. Third Quarter Highlights Third quarter revenue was $100.7 million in fiscal 2024 versus $102.2 million in fiscal 2023, reflecting growth in our Department of Health and Human Services portfolio offset by small business set-aside contract conversions.Earnings were $1.1 million, or $0.08 per diluted share, for the th
ATLANTA, July 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal third quarter ended June 30, 2024 on July 31, 2024 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, August 1, 2024, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow. In
ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2024. Second Quarter Highlights Second quarter revenue was $101.0 million in fiscal 2024 versus $99.4 million in fiscal 2023Earnings were $1.8 million, or $0.12 per diluted share, for the second quarter of fiscal 2024 versus $0.8 million, or $0.06 per diluted share, for the second quarter of fiscal 2023Earnings before interest, taxes, deprecia
4 - DLH Holdings Corp. (0000785557) (Issuer)
4 - DLH Holdings Corp. (0000785557) (Issuer)
4 - DLH Holdings Corp. (0000785557) (Issuer)
DLH Hldgs (NASDAQ:DLHC) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is a 100 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $101.007 million which beat the analyst consensus estimate of $99.000 million by 2.03 percent. This is a 1.60 percent increase over sales of $99.417 million the same period last year.
DLH Hldgs (NASDAQ:DLHC) reported its Q1 earnings results on Wednesday, January 31, 2024 at 04:15 PM. Here's what investors need to know about the announcement. Earnings DLH Hldgs beat estimated earnings by 25.0%, reporting an EPS of $0.15 versus an estimate of $0.12. Revenue was up $25.07 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.03 which was followed by a 1.74% drop in the share price the next day. Here's a look at DLH Hldgs's past performance: Quarter Q4 2023 Q3 2023 Q2 2023 Q1 2023 EPS Estimate 0.13 0.10 0.16 0.19 EPS Actual 0.16 0.12 0.06 0.25 Revenue Estimate 103.00M 102.00M 104.00M 78.00M Revenue Actual 101
DLH Hldgs (NASDAQ:DLHC) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.12 by 25 percent. This is a 40 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $97.85 million which missed the analyst consensus estimate of $101.00 million by 3.12 percent. This is a 34.44 percent increase over sales of $72.78 million the same period last year.
8-K - DLH Holdings Corp. (0000785557) (Filer)
10-Q - DLH Holdings Corp. (0000785557) (Filer)
8-K - DLH Holdings Corp. (0000785557) (Filer)
SC 13G - DLH Holdings Corp. (0000785557) (Subject)
SC 13G/A - DLH Holdings Corp. (0000785557) (Subject)
SC 13G/A - DLH Holdings Corp. (0000785557) (Subject)
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors. "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we wo
ATLANTA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of innovative health research, services, and solutions to federal agencies, today announced G. Maliek Ferebee has been appointed as Chief Human Resources Officer (CHRO). In this role, Mr. Ferebee will be responsible for all aspects of the company's human resources operations, including talent acquisition and development, employee engagement, diversity and inclusion, performance management, compensation and benefits, and more. He will serve as a member of the Executive Leadership Team, working to ensure that the company has the talent and resources necessary to grow and
ATLANTA, July 31, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal health IT and readiness agencies, today announced financial results for its fiscal third quarter ended June 30, 2024. Third Quarter Highlights Third quarter revenue was $100.7 million in fiscal 2024 versus $102.2 million in fiscal 2023, reflecting growth in our Department of Health and Human Services portfolio offset by small business set-aside contract conversions.Earnings were $1.1 million, or $0.08 per diluted share, for the th
ATLANTA, July 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal third quarter ended June 30, 2024 on July 31, 2024 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, August 1, 2024, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow. In
ATLANTA, May 28, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced that management will participate in the following investor events in June: • June 4: The Stifel 2024 Cross Sector Insight Conference at the InterContinental Boston • June 5: The Baird 2024 Global Consumer, Technology & Services Conference at the InterContinental New York Barclay Institutional investors are encouraged to contact these events directly to set up time with the management. Presen